| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.818 | 12.070 | 11.245 | 10.853 | 10.027 | 10.916 | 12.471 | 28.000 | 32.969 |
| Total Income - EUR | - | 7.818 | 12.070 | 11.246 | 12.960 | 10.027 | 10.917 | 12.472 | 28.002 | 32.972 |
| Total Expenses - EUR | - | 1.590 | 2.756 | 539 | 478 | 70 | 78 | 1.206 | 8.457 | 10.272 |
| Gross Profit/Loss - EUR | - | 6.228 | 9.314 | 10.707 | 12.483 | 9.957 | 10.839 | 11.267 | 19.545 | 22.700 |
| Net Profit/Loss - EUR | - | 5.994 | 8.415 | 10.370 | 12.094 | 9.680 | 10.518 | 10.902 | 16.564 | 19.314 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Laborgen Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 894 | 556 | 242 | 0 | 0 | 0 | 0 | 767 | 3.159 |
| Current Assets | - | 15.440 | 7.994 | 14.712 | 20.308 | 17.694 | 11.962 | 11.051 | 8.791 | 16.685 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 250 | 967 | 421 | 413 | 404 | 406 | 404 | 10.052 |
| Cash | - | 15.440 | 7.745 | 13.745 | 19.887 | 17.280 | 11.558 | 10.645 | 8.387 | 6.633 |
| Shareholders Funds | - | 6.001 | 8.468 | 13.705 | 20.210 | 17.643 | 11.387 | 10.951 | 6.659 | 19.703 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 10.339 | 90 | 1.249 | 98 | 51 | 576 | 100 | 3.339 | 287 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Laborgen Med Srl